The development of gel alveolar organoids as a potential screening platform could potentially revolutionize the field of medical research. Imagine being able to accurately test the efficacy of new drugs or treatments on a 3D model that closely mimics the structure and function of human lung tissue. The implications for respiratory diseases such as asthma, chronic obstructive pulmonary disease, and even COVID-19 could be immense. Could this new technology be the breakthrough researchers have been waiting for?

Read Full Article Here

source: Phys.org